European Journal of Internal Medicine
Volume 19, Issue 1 , Pages 60-62, January 2008

Unexpected metastatic pheochromocytoma — An unusual presentation

  • Tanja Birrenbach

      Affiliations

    • Department of Internal Medicine, University Hospital Bern, CH-3010 Bern, Switzerland
  • ,
  • Zeno Stanga

      Affiliations

    • Department of Internal Medicine, University Hospital Bern, CH-3010 Bern, Switzerland
  • ,
  • Philippe Cottagnoud

      Affiliations

    • Department of Internal Medicine, University Hospital Bern, CH-3010 Bern, Switzerland
  • ,
  • Armin Stucki

      Affiliations

    • Department of Internal Medicine, University Hospital Bern, CH-3010 Bern, Switzerland
    • Pneumology, Berner Rehabilitation Center, Heiligenschwendi, Switzerland
    • Corresponding Author InformationCorresponding author. FMH Internal, Respiratory and Intensive Care Medicine, Policlinic and Clinic for Internal Medicine, University Hospital Bern, Freiburgstrasse 10, 3010 Bern, Switzerland. Tel.: +41 31 632 05 24; fax: +41 31 382 43 60.

Received 24 October 2006; accepted 15 February 2007. published online 20 September 2007.

Abstract 

The classic triad of pheochromocytoma consists of episodic headache, sweating, and tachycardia. General clinicians should be aware, however, that this rare entity might present with a wide spectrum of clinical symptoms. We recently observed a noteworthy case of malignant pheochromocytoma where there was a lack of specific symptoms despite an advanced tumor stage. Malignancy is an important cause of mortality. Reliable diagnosis of malignancy depends upon evidence of local invasion, distant metastases, or recurrence. As in our case, new scintigraphic methods, such as 111-In-pentetreotide scintigraphy (Octreoscan), may occasionally reveal 123-I-metaiodobenzylguanidine-negative distant metastases and help to establish an early diagnosis of malignancy. Tumor size, and perhaps even biochemical profile, may be factors increasing the likelihood of a malignant process and may contribute to early identification of patients at risk.

Keywords: Pheochromocytoma, Malignancy, Hypertension, Dopamine

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0953-6205(07)00170-7

doi:10.1016/j.ejim.2007.02.029

European Journal of Internal Medicine
Volume 19, Issue 1 , Pages 60-62, January 2008